YS
YS Biopharma Co., Ltd. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website ysbiopharm.com
- Employees(FY) 754
- ISIN KYG9845F1090
Performance
+34.94%
1W
+7.75%
1M
+136.91%
3M
+92.31%
6M
+85.91%
YTD
-37.5%
1Y
Profile
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.
Technical Analysis of YS 2024-05-03
Overview:
In the last 5 trading days, YS stock has shown a mixed performance based on various technical indicators. The stock price has fluctuated within a narrow range, indicating indecision in the market. We will analyze the trend, momentum, volatility, and volume indicators to determine the possible future stock price movement for YS.
Trend I...
Recent News & Updates
- 2024-05-07 04:20
- 2024-04-28 20:00
- 2024-04-21 21:10
- 2024-04-18 23:52
- 2024-04-18 19:00
- 2024-04-17 20:00
- 2024-04-15 20:00
- 2024-04-08 22:06
- 2024-04-08 20:00
- 2024-04-02 20:00
- 2024-03-04 19:00
- 2024-02-22 04:00
- 2024-02-17 15:30
/C O R R E C T I O N -- YS Biopharma Co., Ltd./(Yahoo Finance)
- 2024-02-16 07:20
- 2024-02-16 04:36
- 2024-02-13 19:00
- 2024-02-13 18:50
- 2024-02-11 19:50
- 2024-02-08 17:30
- 2024-02-08 05:10
- 2024-01-24 03:00
- 2024-01-22 09:51
- 2024-01-22 04:00
- 2024-01-07 19:00
- 2023-12-20 03:30
- 2023-12-20 03:15
/DISREGARD RELEASE: YS Biopharma/(Redinews)
- 2023-12-19 19:56
- 2023-11-13 19:30
- 2023-10-30 20:30
- 2023-10-25 20:30
YS Biopharma Announces Receipt of Nasdaq Notice(Prnewswire)
Page 1 of 2
previousnext